Hinokitiol
CAS 499-44-5
Hinokitiol (CAS 499-44-5) is a pharmaceutical compound with 7 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | GI50 | 13169.595846153847 nM | 65 | - |
| - | Potency | 22359.440384615384 nM | 42 | - |
| - | MIC | 20.247916666666665 ug.mL-1 | 24 | - |
| - | IC50 | 8639.1875 nM | 16 | - |
| - | Ki | 2795.171 nM | 10 | - |
| - | IC50 | 0.3857142857142857 ug.mL-1 | 7 | - |
| - | EC50 | 4800 nM | 1 | - |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| .BETA.-THUJAPLICIN | 1312538 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Hinokitiol used for in pharmaceutical contexts?
Hinokitiol (CAS 499-44-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Hinokitiol?
No adverse-event association or SIDER side-effect rows are rendered for Hinokitiol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Hinokitiol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Hinokitiol with EU status "permitted".
What clinical phase is Hinokitiol in?
No phase 1-4 clinical development badge is rendered for Hinokitiol because the matched compound identifier rows do not contain a max-phase value.